MAPK8 and Parkinson disease: Another experiment also showed that the primary astrocytes pretreatment by silibinin (a constituent of silymarin) effectively inhibited astroglial activation and decreased ERK and JNK phosphorylation before MPP+ treatment in an acute PD model induced by MPTP (57).